Version 2.78

Description

Ombitasvir (ABT-267) is a hepatitis C virus (HCV) NS5A inhibiting antiviral drug for the treatment of HCV infection. PMID: 25451055. United States FDA approved ombitasvir-paritaprevir-ritonavir and dasabuvir for the treatment of genotype 1 chronic hepatitis C infection in adults, including patients with compensated cirrhosis. Source: Regenstrief LOINC

Basic Part Properties

Part Display Name
Ombitasvir
Part Type
Component (Describes the core component or analyte measured)
Created On
2016-06-24
Construct for LOINC Short Name
Ombitasvir

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP220250-7

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 翁比他韦
Synonyms: CAS 1258226-87-7;C50H67N7O8;2,2''-[[(2S,5S)-1-[4-(1,1-Dimethylethyl)phenyl]-2,5-pyrrolidinediyl]di-4,1-phenylene]bis[N-(methoxycarbonyl)-L-valyl-L-prolinamide;ABT 267
es-ES Spanish (Spain) Ombitasvir
it-IT Italian (Italy) Ombitasvir